GSK2656157 (Standard)
GSK2656157 (Standard) is the analytical standard of GSK2656157 (HY-13820). This product is intended for research and analytical applications. GSK2656157 is a selective and ATP-competitive inhibitor of protein Kinase R (PKR)-like endoplasmic reticulum Kinase (PERK) with an IC50 of 0.9 nM.
For research use only. We do not sell to patients.
- CAS No.: 1337532-29-2
- Formula: C23H21FN6O
- Molecular Weight:416.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1337532-29-2
-
Molecular Weight 416.45
-
Formula C23H21FN6O
-
SMILES
CC1=CC=CC(CC(N2CCC3=C2C=CC(C4=CN(C)C5=NC=NC(N)=C54)=C3F)=O)=N1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Atkins C, et al. Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 2013 Mar 15;73(6):1993-2002. [Content Brief]
[2]. Krishnamoorthy J, et al. Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications. Cell Cycle. 2014 Mar 1;13(5):801-6. [Content Brief]
[3]. Ando T, et al. GSK2656157, a PERK inhibitor, reduced LPS-induced IL-1β production through inhibiting Caspase 1 activation in macrophage-like J774.1 cells. Immunopharmacol Immunotoxicol. 2016 Aug;38(4):298-302. [Content Brief]
[4]. Zhao Q, et al. Thioredoxin-interacting protein links endoplasmic reticulum stress to inflammatory brain injury and apoptosis after subarachnoid haemorrhage. J Neuroinflammation. 2017 May 11;14(1):104. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)